Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Animesh Pardanani(Mayo Clinic in Arizona), Rebecca R. Laborde(Mayo Clinic), Terra L. Lasho(Mayo Clinic), Christy M. Finke(Mayo Clinic), Kebede H. Begna(Mayo Clinic), Aref Al‐Kali(Mayo Clinic), William J. Hogan(Mayo Clinic), Mark R. Litzow(Mayo Clinic), Alexey A. Leontovich(Mayo Clinic), Mark Kowalski, Ayalew Tefferi(Mayo Clinic)
Leukemia
March 5, 2013
Cited by 229Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis